Answers are grounded in this paper and cite their sources.
Innovative additives enhance crystallization and defect control in perovskite, suggesting improved efficiency.
An excellent reproducibility of high-quality perovskite thin films is imperative for the commercialization of perovskite solar cells. Multifunctional additive engineering is a promising strategy to tackle this challenge as it facilitates simultaneous control over crystallization processes and defect passivation. Here, an innovative strategy is proposed, leveraging -OH, -NH2, and -Cl to precisely tune the dipole moment and electronic configuration of multifunctional modified 4-chloro-3-sulfonamide benzoic acid (CSBA) through substituent inductive and conjugation effects. The CSBA derivatives were applied as molecular additives to optimize the chemical interaction with undercoordinated Pb2+ and FAI, thereby modulating the defects and crystallization dynamics of perovskite. The results demonstrate that all three additives exhibited synergistic effects, among which -OH-substituted OH-CSBA significantly retards the crystallization process, correlating with its larger dipole moment relative to NH2-CSBA and Cl-CSBA. This is conducive to obtaining large grain size and low-defect density perovskite films. Consequently, the device based on OH-CSBA exhibits an optimal power conversion efficiency (PCE) of 25.39%, along with high reproducibility and remarkable stability.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: